Skip to main content
SpringerLink
Log in

Low rectal cancer

Impact of radiation and chemotherapy on surgical treatment

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

INTRODUCTION: The aim of this study was to evaluate the impact of combined radiotherapy and chemotherapy (leucovorin and 5-fluorouracil) on the treatment of potentially resectable low rectal cancer using the following end points: 1) toxicity of this combined modality regimen; 2) clinical and pathologic response rate and local control; 3) downstaging of the tumor and its influence on the number of sphincter-saving operations; 4) disease-free interval, patterns of relapse, and overall survival. METHODS: From 1991 to 1996, 118 patients with potentially resectable cases of histologically proven adenocarcinoma and no distant metastases were enrolled into this protocol. All patients were evaluated by clinical and proctologic examination, abdominal computed tomography, transrectal ultrasound, and chest radiography. Therapy consisted of 5,040 cGy (6 weeks) and concurrent leucovorin (20/mg/m2/day) with bolus doses of 5-fluorouracil administered intravenously at 425 mg/m2/day for three consecutive days on the first and last three days of radiation therapy. After two months, all patients underwent repeat evaluation and biopsy of any suspected residual lesions or scar tissue. RESULTS: Median follow-up was 36 months. Toxicity of chemotherapy regimen was minimum. Thirty-six patients (30.5 percent) were classified as being complete responders. In six of these patients, complete response was confirmed by the absence of tumor in the surgical specimens (3 abdominoperineal resections and 3 proctosigmoidectomies with coloanal anastomosis). In the remaining 30 patients, confirmation of a complete response was made by the absence of symptoms, negative findings on physical examination, and biopsy, transrectal ultrasound, and pelvic computed tomographic test results during follow-up. Eighty-two patients (69.4 percent) were considered incomplete responders. Residual lesions had already been identified during the first examination in 74 patients. In the other eight patients, residual tumor was only identified after 3 to 14 months. All patients underwent surgical treatment, except one patient who refused surgery. Eighty-seven patients underwent 90 surgical procedures: local excision, 9; coloanal anastomosis, 36; abdominoperineal resection, 4; Hartmann's procedure, 1. Isolated local recurrences occurred in five patients (4.3 percent) and combined local and distant failure in eight patients (6.7 percent). Ninety patients are alive and disease-free at a median follow-up of 36 months. CONCLUSIONS: Combined up-front chemoradiotherapy was associated with tolerable and acceptable side effects. A significant number of patients had complete disappearance of their tumors (30.5 percent) within a median follow-up of 36 months. This regimen spared 26.2 percent of patients from surgical treatment and allowed sphincter-saving management in 38.1 percent of patients who may have required abdominoperineal resection. Preliminary results of this trial suggests a reduction in the number of local recurrences and reinforces the concept that infiltrative low rectal cancer may be initially treated by chemoradiotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aleman BM, Bartelink H, Gunderson LL. The current role of radiotherapy in colorectal cancer. Eur J Cancer 1995;31A:1333–9.

    Google Scholar 

  2. O'Connell MJ. A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer: a Mayo Clinic/North Central Cancer Treatment Group Study. Cancer 1989;63:1026–30.

    PubMed  Google Scholar 

  3. Cohen AM. Adjuvant therapy in rectal cancer. Hepatogastroenterology 1992;39:215–21.

    PubMed  Google Scholar 

  4. Chari RS, Tyler DS, Anscher MS,et al. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 1995;221:778–87.

    Google Scholar 

  5. Påhlman L & Glimelius B. The value of adjuvant radio-(chemo)therapy for rectal cancer. Eur J Cancer 1995;31A:1347–50.

    Google Scholar 

  6. Boulis-Wassif S, Gérard A, Loygue J, Camelot D, Buyse M, Suez N. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery: Trial of the European Organization on Research and Treatment of Gastrointestinal Cancer Cooperative Group. Cancer 1984;53:1811–8.

    PubMed  Google Scholar 

  7. Rider WD, Palmer JA, Mahoney LJ, Robertson CT. Preoperative irradiation in operable cancer of the rectum: report of the Toronto Trial. Can J Surg 1977;20:335–8.

    PubMed  Google Scholar 

  8. Cohen AM, Minsky BD. A phase I trial of preoperative radiation proctectomy and endo-anal reconstruction. Arch Surg 1990;125:247–51.

    PubMed  Google Scholar 

  9. Minsky BD, Kemeny N, Cohen AM,et al. Preoperative high-dose leucoverin/5-fluorouracil and radiation therapy for unresectable rectal cancer. Cancer 1991;67:2859–66.

    PubMed  Google Scholar 

  10. Minsky BD, Cohen AM, Kemeny N,et al. Enhancement of radiation-induced downstaging of rectal cancer by fuorouracil and high-dose leucoverin chemotherapy. J Clin Oncol 1992;10:79–84.

    PubMed  Google Scholar 

  11. Byfield JE, Frankel SS, Sharp SS, Hornback CL, Callipari FB. Phase I and pharmacological study of 72 hour infused and hyperfractionated cyclical radiation. Int J Radiat Oncol Biol Phys 1985;11:791–800.

    PubMed  Google Scholar 

  12. Haghbin M, Sischy B, Hinson J. Combined modality therapy in poor prognostic rectal adenocarcinoma. Radiother Oncol 1988;13:75–81.

    Article  PubMed  Google Scholar 

  13. Nadalin W, Habr-Gama A. O papel da radioterapia no câncer retal. Oncologia Atual 1994;4:124–33.

    Google Scholar 

  14. Mohiuddin M, Dobelbower RR, Turalba C, Kramer S, Marks G. A selective sandwich technique of adjuvant radiotherapy in the treatment of rectal cancer: a preliminary experience. Dis Colon Rectum 1979;22:1–4.

    PubMed  Google Scholar 

  15. Winchester DP, Cox JD. Standards for breast-conservation treatment. Cancer J Clin 1992;42:135–63.

    Google Scholar 

  16. Meterissian S, Skibber J, Rich T,et al. Patterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinoma. Ann Surg Oncol 1994;1:111–6.

    PubMed  Google Scholar 

  17. Neville R, Fielding LP, Amendola C. Local tumor recurrence after curative resection for rectal cancer: a ten-hospital review. Dis Colon Rectum 1987;30:12–7.

    PubMed  Google Scholar 

  18. Rich T, Gunderson LL, Lew R, Galdibini JJ, Cohen AM, Donaldson G. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 1983;52:1317–29.

    PubMed  Google Scholar 

  19. Gastrointestinal Tumor Study Group. Survival after postoperative combination treatment of rectal carcinoma. N Engl J Med 1986;315:1294–5.

    Google Scholar 

  20. Cummings BJ. Radiation therapy for colorectal cancer. Surg Clin North Am 1993;73:167–81.

    PubMed  Google Scholar 

  21. Kodner IJ, Shemesh EI, Fry RD,et al. Preoperative irradiation for rectal cancer: improved local control and long-term survival. Ann Surg 1989;209:194–9.

    PubMed  Google Scholar 

  22. Reis Neto JA, Quilici FA, Reis JA Jr. A comparison of nonoperativeversus preoperative radiotherapy in rectal carcinoma: a 10-year randomized trial. Dis Colon Rectum 1989;32:702–10.

    PubMed  Google Scholar 

  23. Enker WE, Paty PB, Minsky BD, Cohen AM. Restorative or preservative operations in the treatment of rectal cancer. Surg Oncol Clin North Am 1992;1:57–69.

    Google Scholar 

  24. Marks G, Mohiuddin M, Masoni L, Montori A. High-dose preoperative radiation therapy as the key to extending sphincter-preservation surgery for cancer of the distal rectum. Surg Oncol Clin North Am 1992;1:71–86.

    Google Scholar 

  25. Minsky BD. Rectal Cancer: the preoperative combined modality approach. Gastrointest Cancer 1994;2:254–60.

    Google Scholar 

  26. Poon MA, O'Connell MJ, Moertel CG,et al. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal cancer. J Clin Oncol 1989;7:1407–18.

    PubMed  Google Scholar 

  27. Rotman M, Aziz H. Concomitant continuous infusion chemotherapy and radiation. Cancer 1990;65:823–35.

    PubMed  Google Scholar 

  28. NIH Consensus Conference. Adjuvant therapy for patient with colon and rectal cancer. JAMA 1990;264:1444–50.

    Google Scholar 

  29. Erlichman C, Fine S, Wong A, Elhakim T. A randomized trial of 5-FU and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 1988;6:469–75.

    PubMed  Google Scholar 

  30. Napoleon B, Pujol B, Berger F, Valette PJ, Gerard JP, Souquet JC. Accuracy of endosonography in the staging of rectal cancer treated by radiotherapy. Br J Surg 1991;78:785–8.

    PubMed  Google Scholar 

  31. Habr-Gama A. Cirurgia radical do câncer do reto com conservação do sistema esfincteriano. Prensa Med Argent 1980;67:698–703.

    Google Scholar 

  32. Letschert JG, Lebesque JV, de Boer RW, Hart AA, Bartelink H. Dose-volume correlation in radiation related late small bowel complications: a clinical study. Radiother Oncol 1990;18:307–20.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Colorectal Unit of the Department of Gastroenterology and the Department of Radiotherapy, University of São Paulo, São Paulo, Brazil

    Angelita Habr-Gama M.D., Pedro M. Santinho B. de Souza M.D., Ulysses Ribeiro Jr. M.D., Wladimir Nadalin M.D., René Gansl M.D., Afonso H. S. e Sousa Jr. M.D., Fábio Guilherme Campos M.D. & Joaquim Gama-Rodrigues M.D.

Authors
  1. Angelita Habr-Gama M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pedro M. Santinho B. de Souza M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ulysses Ribeiro Jr. M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wladimir Nadalin M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. René Gansl M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Afonso H. S. e Sousa Jr. M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fábio Guilherme Campos M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Joaquim Gama-Rodrigues M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Read at the meeting of The American Society of Colon and Rectal Surgeons, Philadelphia, Pennsylvania, June 22 to 26, 1997.

About this article

Cite this article

Habr-Gama, A., de Souza, P.M.S.B., Ribeiro, U. et al. Low rectal cancer. Dis Colon Rectum 41, 1087–1096 (1998). https://doi.org/10.1007/BF02239429

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02239429

Key words

Search

Navigation